About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01233817

Progressive Strength Training in Spinal Muscular Atrophy

The proposed feasibility study is necessary to test if children and young adults will participate in and adhere to a 12-week, home-based, supervised progressive strength training exercise program and ...

Lead sponsor: University of Utah•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Utah

Age

5 - 21 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•age 5-21 years
•diagnosis of SMA type II or III
•at least antigravity strength in elbow flexors
•ability to follow commands and stay on task
•place of residence within a 60-minute or 60-mile drive of the University of Utah

Exclusion Criteria

•planned surgery or out-of-town trips during the proposed intervention period
•inability to travel to study center for testing
•neurological diagnosis other than SMA

Related studies

RECRUITINGPhase 4

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

NCT05861986 · Muscular Atrophy, Spinal

RECRUITINGPhase 2

A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

NCT05808764 · Muscular Atrophy, Spinal

Natural History of SMA

NCT05755451 · Muscular Atrophy, Spinal

Active Not Recruiting

Adult Spinal Muscular Atrophy (SMA) China Registry

NCT05618379 · Muscular Atrophy, Spinal

Active Not RecruitingPhase 1

A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec

NCT05575011 · Healthy Volunteer, Muscular Atrophy, Spinal

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 14, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment12

Start dateJun 2010

Last updatedJun 14, 2017

Condition

Muscular Atrophy, Spinal

Locations shown

University of Utah

Salt Lake City, Utah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 14, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions